Effect of vasoactive intestinal peptide on pulmonary surfactants phospholipid synthesis in lung explants

被引:0
作者
Li, L [1 ]
Luo, ZQ [1 ]
Zhou, FW [1 ]
Feng, DD [1 ]
Guan, CX [1 ]
Zhang, CQ [1 ]
Sun, XH [1 ]
机构
[1] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha 410078, Peoples R China
关键词
vasoactive intestinal peptide; pulmonary surfactants; choline-phosphate cytidylyltransferase;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AIM: To investigate the effect of vasoactive intestinal peptide (VIP) on pulmonary surfactants (PS) phospholipid synthesis in cultured lung explants. METHODS: Lung explants were cultured with serum-free medium, [methyl-H-3]choline incorporation, total phospholipid, phosphatidylcholine, activity of choline-phosphate cytidylyltransferase (CCT) and CCTalpha mRNA level in lung explants were determined. RESULTS: (1) VIP (10(-10)-10(-7) mol/L) for 16 h promoted [methyl-H-3]choline incorporation in dose dependence and VIP (10(-8) mol/L) for 2 h-16 h promoted [methyl-H-3]choline incorporation in time dependence. (2) VIP (10(-8) mol/L) enhanced the contents of total phospholipids and phosphatidylcholine in lung explants. (3) VIP (10(-10)-10(-7) mol/L) elevated microsomal CCT activity of lung explants in dose dependence. (4) VIP (10(-8) mol/L) increased expression of CCTalpha mRNA in lung explants and alveolar type II cells (ATII). (5) [D-P-Cl-Phe(6)-Leu(17)]-VIP (10(-6) mol/L), a VIP receptors antagonist, abolished the increase of [H-3]choline incorporation, microsomal CCT activity and CCTalpha mRNA level induced by VIP (10(-8) mol/L) in lung explants. CONCLUSION: VIP could enhance synthesis of phosphatidylcholine, the major component of pulmonary surfactants by enhancing microsomal CCT activity and CCTalpha mRNA level via VIP receptor-mediated pathway.
引用
收藏
页码:1652 / 1658
页数:7
相关论文
共 26 条
[1]   LOW PLASMA-CONCENTRATIONS OF VIP AND ELEVATED LEVELS OF OTHER NEUROPEPTIDES DURING EXACERBATIONS OF ASTHMA [J].
CARDELL, LO ;
UDDMAN, R ;
EDVINSSON, L .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (12) :2169-2173
[2]   CTP:phosphocholine cytidylyltransferase:: Insights into regulatory mechanisms and novel functions [J].
Clement, JM ;
Kent, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) :643-650
[3]   RELEASE OF VASOACTIVE INTESTINAL POLYPEPTIDE IN MAST-CELLS BY HISTAMINE LIBERATORS [J].
CUTZ, E ;
CHAN, W ;
TRACK, NS ;
GOTH, A ;
SAID, SI .
NATURE, 1978, 275 (5681) :661-662
[4]   ACTIVATION OF CTP - PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE IN RAT LUNG BY FATTY-ACIDS [J].
FELDMAN, DA ;
BRUBAKER, PG ;
WEINHOLD, PA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (01) :53-59
[5]  
GOETZL EJ, 1988, J BIOL CHEM, V263, P9083
[6]   Vasoactive intestinal polypeptide as mediator of asthma [J].
Groneberg, DA ;
Springer, J ;
Fischer, A .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (05) :391-401
[7]  
Haagsman HP, 2003, ACTA PHARMACOL SIN, V24, P1301
[8]   IN-VIVO DYNAMICAL DISTRIBUTION OF I-131 VIP IN THE RAT STUDIED BY GAMMA-CAMERA [J].
HASSAN, M ;
REFAI, E ;
ANDERSSON, M ;
SCHNELL, PO ;
JACOBSSON, H .
NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (06) :865-872
[9]  
Hu L, 1997, J CELL BIOCHEM, P117
[10]   CLONING AND EXPRESSION OF RAT-LIVER CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE - AN AMPHIPATHIC PROTEIN THAT CONTROLS PHOSPHATIDYLCHOLINE SYNTHESIS [J].
KALMAR, GB ;
KAY, RJ ;
LACHANCE, A ;
AEBERSOLD, R ;
CORNELL, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6029-6033